PIEVANI, ALICE SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 3.541
AS - Asia 2.023
EU - Europa 2.001
SA - Sud America 310
AF - Africa 50
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.935
Nazione #
US - Stati Uniti d'America 3.450
SG - Singapore 724
IT - Italia 569
CN - Cina 515
RU - Federazione Russa 301
HK - Hong Kong 289
DE - Germania 276
BR - Brasile 270
IE - Irlanda 249
SE - Svezia 185
VN - Vietnam 124
GB - Regno Unito 113
ID - Indonesia 77
IN - India 71
CA - Canada 69
UA - Ucraina 68
FI - Finlandia 52
FR - Francia 46
KR - Corea 37
JP - Giappone 34
TR - Turchia 27
ZA - Sudafrica 24
PK - Pakistan 21
PL - Polonia 21
AR - Argentina 20
NL - Olanda 20
BD - Bangladesh 19
MX - Messico 17
AT - Austria 16
DK - Danimarca 15
IR - Iran 15
BE - Belgio 14
ES - Italia 13
IQ - Iraq 12
TW - Taiwan 12
MA - Marocco 9
CH - Svizzera 8
RO - Romania 8
AU - Australia 7
CO - Colombia 7
EG - Egitto 7
LT - Lituania 7
NO - Norvegia 6
PH - Filippine 6
CZ - Repubblica Ceca 5
TH - Thailandia 5
AE - Emirati Arabi Uniti 4
EC - Ecuador 4
IL - Israele 4
KZ - Kazakistan 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
LB - Libano 3
NP - Nepal 3
PY - Paraguay 3
AL - Albania 2
AM - Armenia 2
CI - Costa d'Avorio 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
PA - Panama 2
PE - Perù 2
RS - Serbia 2
TN - Tunisia 2
VE - Venezuela 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
CL - Cile 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
HN - Honduras 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
SN - Senegal 1
UG - Uganda 1
UY - Uruguay 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.935
Città #
Ann Arbor 534
Singapore 462
Ashburn 370
Hong Kong 286
Dublin 245
Chandler 237
Fairfield 163
Frankfurt am Main 154
Wilmington 154
Milan 148
Houston 146
Woodbridge 143
New York 105
Los Angeles 102
Seattle 99
Beijing 88
Dearborn 80
Santa Clara 70
Jakarta 66
Hefei 62
Shanghai 61
Jacksonville 60
Cambridge 57
Princeton 55
Dallas 50
Ho Chi Minh City 46
Bergamo 43
São Paulo 33
Chicago 32
Tokyo 32
Denver 29
Seoul 29
Nanjing 28
Buffalo 27
Hanoi 25
Munich 24
Altamura 23
Lawrence 22
Moscow 22
Rome 22
Helsinki 20
Johannesburg 18
Lissone 17
Montreal 17
Monza 17
The Dalles 17
Warsaw 17
London 16
Orem 16
Brussels 14
Council Bluffs 14
Turin 14
Portsmouth 13
San Diego 13
Stockholm 13
Carrboro 12
Nuremberg 12
Toronto 12
Borgomanero 11
Brooklyn 11
Chennai 11
Lachine 11
Ottawa 11
Guangzhou 10
Hyderabad 10
Jinan 10
Lappeenranta 10
Poplar 10
Pune 10
Carate Brianza 9
Contursi 9
Lahore 9
Mumbai 9
Nanchang 9
Vienna 9
Belo Horizonte 8
Bologna 8
Hangzhou 8
Hebei 8
Kunming 8
Mexico City 8
Shenyang 8
Turku 8
Ankara 7
Atlanta 7
Baghdad 7
Boardman 7
Brasília 7
Desio 7
Dhaka 7
Florence 7
Phoenix 7
San Francisco 7
Amsterdam 6
Bergen 6
Brescia 6
Cagliari 6
Kocaeli 6
Manchester 6
Missaglia 6
Totale 5.051
Nome #
Acute myeloid leukaemia niche regulates response to L-asparaginase 403
Mesenchymal stromal cells from Shwachman-Diamond syndrome patients fail to recreate a bone marrow niche in vivo and exhibit impaired angiogenesis 348
Fludarabine as a cost-effective adjuvant to enhance engraftment of human normal and malignant hematopoiesis in immunodeficient mice 319
Acute myeloid leukemia shapes the bone marrow stromal niche in vivo 296
Human umbilical cord blood-borne fibroblasts contain marrow niche precursors that form a bone/marrow organoid in vivo 293
Cytokine-induced killer (cik) cell cultures for the adoptive immunotherapy of hematological malignancies: characterization and new therapeutic strategies for clinical application 285
Location First: Targeting Acute Myeloid Leukemia Within Its Niche 285
Human aplastic anaemia-derived mesenchymal stromal cells form functional haematopoietic stem cell niche in vivo 281
CXCR4-MODIFIED CD33.CAR-CIK WITH ENHANCED BONE MARROW HOMING IN ACUTE MYELOID LEUKEMIA 268
Neonatal combination therapy improves some of the clinical manifestations in the Mucopolysaccharidosis type I murine model 266
Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I 238
Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the Acute Myeloid Leukemia burden 230
Catch me if you can: how AML and its niche escape immunotherapy 220
Heterogeneity of the bone marrow niche in patients with myeloproliferative neoplasms: ActivinA secretion by mesenchymal stromal cells correlates with the degree of marrow fibrosis 207
Neonatal bone marrow transplantation prevents bone pathology in a mouse model of mucopolysaccharidosis type I 206
Overexpression of CXCR4 receptor on CD33.CAR-CIK cells enhances the control of the Acute Myeloid Leukemia burden 205
Cytokine-induced killer cells are terminallydifferentiated activated CD8 cytotoxic T-EMRA lymphocytes 201
Combining the Expression of CD33.CAR and CXCR4 to Increase CAR-CIK Cell Homing to Bone Marrow Niche and Leukemic Stem Cell Eradication in Acute Myeloid Leukemia 201
Cellule CD33.CAR-CIK ingegnerizzate per co-esprimere il recettore CXCR4 al fine di aumentare la capacità di migrazione all’interno della nicchia midollare nella leucemia mieloide acuta 201
Enhanced killing of human B-cell lymphoma targets by combined use of cytokine-induced killer cell (CIK) cultures and anti-CD20 antibodies 195
Comparative analysis of multilineage properties of mesenchymal stromal cells derived from fetal sources shows an advantage of mesenchymal stromal cells isolated from cord blood in chondrogenic differentiation potential 193
Dual-functional capability of CD3 +CD56 + CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity 190
Overexpression of CXCR4 Enhances the Efficacy of CAR-T Therapy for Acute Myeloid Leukemia 189
Combining the expression of CD33.CAR and CXCR4 to augment CAR-CIKs homing to bone marrow niche and leukemic stem cell eradication in acute myeloid leukemia 184
Neonatal cellular and gene therapies for mucopolysaccharidoses: the earlier the better? 177
Engineering tandem CD33xCD146 CAR CIK (cytokine-induced killer) cells to target the acute myeloid leukemia niche 171
Establishment of bone marrow and hematopoietic niches in vivo by reversion of chondrocyte differentiation of human bone marrow stromal cells 170
Generation of CIK cells co-expressing CXCR4 and CD33.CAR with improved homing and antitumor activity for AML 170
Feasibility and Safety of Adoptive Immunotherapy with CIK Cells after Cord Blood Transplantation 169
CARs are sharpening their weapons 164
Improving Bone Marrow Homing and Persistence of CD33.CAR-CIK Cells By Overexpression of a Gain-of-Function Variant of CXCR4 to Increase Efficacy in Acute Myeloid Leukemia 159
Bone marrow mesenchymal stromal cells support translation in refractory acute myeloid leukemia 150
Modeling skeletal dysplasia in Hurler syndrome using patient-derived bone marrow osteoprogenitor cells 138
Ingegnerizzazione di cellule CD33.CAR-CIK con una variante gain-of-function del recettore CXCR4 per aumentarne migrazione e persistenza nella nicchia midollare 137
AML alters bone marrow stromal cell osteogenic commitment via Notch signaling 136
Bone marrow mesenchymal stromal cells induce nitric oxide synthase-dependent differentiation of CD11b+ cells that expedite hematopoietic recovery 127
A Question of Frame: The Role of the Bone Marrow Stromal Niche in Myeloid Malignancies 126
CD14 positive cells accelerate hematopoietic stem cell engraftment 124
MPSI Manifestations and Treatment Outcome: Skeletal Focus 88
Harnessing Mesenchymal Stromal Cells for the Engineering of Human Hematopoietic Niches 59
Neonatal gene therapy effectively prevents disease manifestations in a murine model of Mucopolysaccharidosis type I 37
Totale 8.206
Categoria #
all - tutte 28.038
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.038


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021401 0 0 0 0 0 64 57 62 55 75 42 46
2021/2022477 41 36 40 40 36 41 17 16 18 37 37 118
2022/2023896 100 245 56 101 26 126 20 55 71 10 61 25
2023/2024940 42 33 52 65 93 255 142 58 80 28 14 78
2024/20251.734 81 164 169 79 147 135 110 68 152 242 157 230
2025/20262.186 486 237 283 552 582 46 0 0 0 0 0 0
Totale 8.206